DNMT3A and cancer: The targeted NGS panel used in this study, Oncomine Pan‐Cancer, covers the most commonly detected mutations from solid tumors; however, it does not cover the genes that are commonly associated with hematopoietic stem cells, such as DNMT3A, TET2, and ASXL1 (Ptashkin et al., 2018; Razavi et al., 2019).